NCT03113630|Completed
Virtual Task in Amyotrophic Lateral Sclerosis
Efficacy of Different Interaction Devices Using Virtual Task in Amyotrophic Lateral Sclerosis
Loading search results
Efficacy of Different Interaction Devices Using Virtual Task in Amyotrophic Lateral Sclerosis
Sponsor study identifier
interventional
60
1 country
1
Study Start
February 2, 2016
Actual (reported)Primary Completion
August 3, 2016
Actual (reported)Study Completion
October 4, 2016
Actual (reported)Thirty individuals with ALS (18 men and 12 women, mean age 59 years, range 44-74 years), and 30 healthy controls matched for age and gender, participated. Individuals with ALS and from the control group were randomly divided into three groups, each using a different communication device systems (Kinect®, Leap Motion Controller® or touchscreen) to perform two task phases (acquisition and retention). Performance was then explored in a third phase (transfer) by switching devices (two transfers); so that, all groups had contact with all communication interfaces.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 4, 2016
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 2, 2016
Actual (reported)August 3, 2016
Actual (reported)October 4, 2016
Actual (reported)April 2, 2017
Actual (reported)April 13, 2017
Actual (reported)Motor performance improvement in a virtual Timing Coincident task, comparing performance between LeapMotion, TouchScreen and Kinect.
Analysis of the motor performance using a virtual Coincident timing task in different devices to compare wether a task with or without contact promote better performance for people with Amyotrophic Lateral Sclerosis
3 months
Subjects practice the task and retention TouchScreen, transfer 1 on LeapMotion and transfer 2 on Kinect
Subjects practice the task and retention Kinect, transfer 1 on TouchScreen and transfer 2 on LeapMotion.
Subjects practice the task and retention LeapMotion, transfer 1 on TouchScreen and transfer 2 on Kinect.
Participants performed acquisition and retention on TouchScreen, transfer 1 on Kinect and transfer 2 on LeapMotion.
Participants performed acquisition and retention on Kinect, transfer 1 on TouchScreen and transfer 2 on LeapMotion.
Escola de Artes,Ciencias e Humanidades da Universidade d Sao Paulo
São Paulo, São Paulo, 03828-000, Brazil
Trevizan IL, Silva TD, Dawes H, Massetti T, Crocetta TB, Favero FM, Oliveira ASB, de Araujo LV, Santos ACC, de Abreu LC, Coe S, Monteiro CBM. Efficacy of different interaction devices using non-immersive virtual tasks in individuals with Amyotrophic Lateral Sclerosis: a cross-sectional randomized trial. BMC Neurol. 2018 Dec 17;18(1):209. doi: 10.1186/s12883-018-1212-3.
Carlos BM Monteiro, Ph.D.
University of Sao Paulo
60 participants (actual enrollment reported by the registry).
First Submitted
April 2, 2017
First Posted
April 13, 2017
Study Start
February 2, 2016
Actual (reported)Oral Nutritional Supplementation in Amyotrophic Lateral Sclerosis (ALS) Patients
A Pilot Study of the Utility of 3D Printed Masks for ALS Subjects
Exploratory Study of Biotelemetry in Amyotrophic Lateral Sclerosis
Subjects practice the task and retention TouchScreen, transfer 1 on LeapMotion and transfer 2 on Kinect
Subjects practice the task and retention Kinect, transfer 1 on TouchScreen and transfer 2 on LeapMotion.
Subjects practice the task and retention LeapMotion, transfer 1 on TouchScreen and transfer 2 on Kinect.
Participants performed acquisition and retention on LeapMotion, transfer 1 on TouchScreen and transfer 2 on Kinect.
Participants performed acquisition and retention on TouchScreen, transfer 1 on Kinect and transfer 2 on LeapMotion.
Participants performed acquisition and retention on Kinect, transfer 1 on TouchScreen and transfer 2 on LeapMotion.
Participants performed acquisition and retention on LeapMotion, transfer 1 on TouchScreen and transfer 2 on Kinect.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
August 3, 2016
Actual (reported)Study Completion
October 4, 2016
Actual (reported)Last Updated
April 13, 2017
Record last verified: 2017-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: